SG11202110910TA - Alpha-synuclein assays - Google Patents
Alpha-synuclein assaysInfo
- Publication number
- SG11202110910TA SG11202110910TA SG11202110910TA SG11202110910TA SG11202110910TA SG 11202110910T A SG11202110910T A SG 11202110910TA SG 11202110910T A SG11202110910T A SG 11202110910TA SG 11202110910T A SG11202110910T A SG 11202110910TA SG 11202110910T A SG11202110910T A SG 11202110910TA
- Authority
- SG
- Singapore
- Prior art keywords
- synuclein
- assays
- alpha
- synuclein assays
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841118P | 2019-04-30 | 2019-04-30 | |
| PCT/US2020/030796 WO2020223523A1 (en) | 2019-04-30 | 2020-04-30 | Alpha-synuclein assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110910TA true SG11202110910TA (en) | 2021-11-29 |
Family
ID=73029472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110910TA SG11202110910TA (en) | 2019-04-30 | 2020-04-30 | Alpha-synuclein assays |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220214360A1 (en) |
| EP (1) | EP3963047A4 (en) |
| JP (1) | JP2022530651A (en) |
| CN (1) | CN114341343A (en) |
| AU (1) | AU2020266589A1 (en) |
| CA (1) | CA3136679A1 (en) |
| IL (1) | IL287453A (en) |
| SG (1) | SG11202110910TA (en) |
| WO (1) | WO2020223523A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3203308A1 (en) * | 2020-11-30 | 2022-06-02 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
| CN116840482A (en) * | 2022-03-23 | 2023-10-03 | 浙江大学 | Early diagnosis system for parkinsonism based on exosome synuclein |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7085788B2 (en) | 2003-12-03 | 2006-08-01 | Hitachi, Ltd. | Remote copy system configured to receive both a write request including a write time and a write request not including a write time. |
| EP2282758B1 (en) * | 2008-04-29 | 2018-11-21 | BioArctic AB | Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| SI2949666T1 (en) * | 2008-12-19 | 2019-03-29 | Biogen International Neuroscience Gmbh | Human anti-alpha-synuclein antibodies |
| PT2539366T (en) | 2010-02-26 | 2018-02-13 | Bioarctic Neuroscience Ab | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| EP2649456A4 (en) * | 2010-12-06 | 2015-01-07 | Ridge Diagnostics Inc | Biomarkers for monitoring treatment of neuropsychiatric diseases |
| US20140241987A1 (en) | 2013-02-28 | 2014-08-28 | United Arab Emirates University | Alpha-synuclein antibodies and uses thereof |
| KR102384115B1 (en) | 2013-10-24 | 2022-04-07 | 나노소믹스 인코포레이티드 | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders |
| JP6255035B2 (en) * | 2013-11-06 | 2017-12-27 | Jsr株式会社 | Separation method, detection method, signal measurement method, disease determination method, drug efficacy evaluation method for disease treatment, kit and liquid composition |
| DK3110977T3 (en) | 2014-02-28 | 2018-07-23 | Exosome Sciences Inc | BRAIN SPECIFIC EXOSOME-BASED DIAGNOSTIC AND EXTRACORPORAL THERAPIES |
| JP6531171B2 (en) * | 2014-06-27 | 2019-06-12 | エックスワイ エバーグリーン テクノロジー カンパニー | Methods for enriching CNS derived exosomes |
| WO2016135280A1 (en) * | 2015-02-26 | 2016-09-01 | Innovative Concepts In Drug Development | Diagnostic markers of cognitive impairments, kits and uses thereof |
| WO2016172598A1 (en) * | 2015-04-22 | 2016-10-27 | The Broad Institute Inc. | Exosomes and uses thereof |
| GB201515223D0 (en) * | 2015-08-27 | 2015-10-14 | Georg August Uni Gottingen Stiftung Offentlichen Rechts Universitatsmedizin | Method of differential diagnosis of dementia with Lewy bodies and Parkinson's disease |
| GB201518675D0 (en) * | 2015-10-21 | 2015-12-02 | Cellcap Technologies Ltd | Detection of structural forms of proteins |
| GB201611840D0 (en) * | 2016-07-07 | 2016-08-24 | Univ Court Of The Univ Of Edinburgh The | Alpha-synuclein detection assay |
| WO2019039179A1 (en) * | 2017-08-22 | 2019-02-28 | 国立大学法人広島大学 | Method for isolating exosome and exosome isolation kit |
| ES2955992T3 (en) * | 2017-12-19 | 2023-12-11 | Chase Therapeutics Corp | Method to evaluate a synucleinopathy |
| GB201803553D0 (en) * | 2018-03-06 | 2018-04-18 | Univ Newcastle | Detection of pathological protein aggregation |
-
2020
- 2020-04-30 CA CA3136679A patent/CA3136679A1/en active Pending
- 2020-04-30 US US17/606,982 patent/US20220214360A1/en active Pending
- 2020-04-30 WO PCT/US2020/030796 patent/WO2020223523A1/en unknown
- 2020-04-30 EP EP20798241.4A patent/EP3963047A4/en active Pending
- 2020-04-30 AU AU2020266589A patent/AU2020266589A1/en active Pending
- 2020-04-30 JP JP2021564474A patent/JP2022530651A/en active Pending
- 2020-04-30 CN CN202080032514.9A patent/CN114341343A/en active Pending
- 2020-04-30 SG SG11202110910TA patent/SG11202110910TA/en unknown
-
2021
- 2021-10-21 IL IL287453A patent/IL287453A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL287453A (en) | 2021-12-01 |
| CN114341343A (en) | 2022-04-12 |
| US20220214360A1 (en) | 2022-07-07 |
| JP2022530651A (en) | 2022-06-30 |
| WO2020223523A1 (en) | 2020-11-05 |
| CA3136679A1 (en) | 2020-11-05 |
| AU2020266589A1 (en) | 2021-10-28 |
| EP3963047A1 (en) | 2022-03-09 |
| EP3963047A4 (en) | 2023-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289112A (en) | Anti-tigit antibodies | |
| SG11202108141VA (en) | Novel cd40-binding antibodies | |
| IL291068A (en) | Anti-cd73 antibodies | |
| IL277687A (en) | Colocalization-by-linkage sandwich assays | |
| IL284584A (en) | Anti-tigit antibodies | |
| GB201811368D0 (en) | Antibody | |
| ZA202108836B (en) | Anti-epha4 antibody | |
| GB201904887D0 (en) | Lifebit al | |
| GB2596456B (en) | Immunoassay for mitragynine | |
| IL287453A (en) | Alpha-synuclein assays | |
| GB201817172D0 (en) | Antibody | |
| GB201905150D0 (en) | Ant-ige antibodies | |
| GB2581174B (en) | Antibodies against hEPCR | |
| GB201917480D0 (en) | Antibodies | |
| GB201900732D0 (en) | Antibodies | |
| IL289160A (en) | Anti-angpt2 antibodies | |
| CA195194S (en) | Can | |
| EP4076343C0 (en) | Retinol-based serum | |
| EP4081546A4 (en) | Novel anti-fgfr2b antibodies | |
| EP4081547A4 (en) | Novel anti-fgfr2b antibodies | |
| IL287629A (en) | Assays | |
| GB202107664D0 (en) | Assays | |
| GB201919062D0 (en) | Antibody | |
| GB201912008D0 (en) | Antibody | |
| SG11201913540VA (en) | Anti-Podoplanin Antibody |